Literature DB >> 9916070

Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons.

M Nyindo1, T M Kariuki, P W Mola, I O Farah, L Elson, R E Blanton, C L King.   

Abstract

Allergic-type immune responses, particularly immunoglobulin E (IgE), correlate with protective immunity in human schistosomiasis. To better understand the mechanisms of parasite elimination we examined the immune correlates of protection in baboons (Papio cynocephalus anubis), which are natural hosts for Schistosoma mansoni and also develop allergic-type immunity with infection. In one experiment, animals were exposed to a single infection (1,000 cercariae) or were exposed multiple times (100 cercariae per week for 10 weeks) and subsequently were cured with praziquantel prior to challenge with 1, 000 cercariae. Singly and multiply infected animals mounted 59 and 80% reductions in worm burden, respectively (P < 0.01). In a second experiment, animals were inoculated with S. mansoni ova and recombinant human interleukin 12 (IL-12). This produced a 37 to 39% reduction in adult worm burden after challenge (P < 0.05). Parasite-specific IgG, IgE, IgM, and peripheral blood cytokine production were evaluated. The only immune correlate of protection in both experiments was levels of soluble adult worm antigen (SWAP)-specific IgE in serum at the time of challenge infection and/or 6 weeks later. Baboons repeatedly infected with cercariae or immunized with ova and IL-12 developed two- to sixfold-greater levels of SWAP-specific IgE in serum than did controls, and this correlated with reductions in worm burden (r2, -0.40 to -0.64; P, <0. 01). Thus, in baboons and unlike mice, adult worm-specific IgE is uniquely associated with acquired immunity to S. mansoni infection. This similar association of parasite-specific IgE and protection among primates infected with schistosomiasis, along with similar pathology, anatomy, and genetic make-up, indicates that baboons provide an excellent permissive experimental model for better understanding the mechanisms of innate and acquired immunity to schistosomiasis in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916070      PMCID: PMC96366     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae.

Authors:  L E Smythies; P S Coulson; R A Wilson
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

2.  Reinfection, exposure and immunity in human schistosomiasis.

Authors:  P Hagan
Journal:  Parasitol Today       Date:  1992-01

3.  Specific IgE antibodies in immune adherence of normal macrophages to Schistosoma mansoni schistosomules.

Authors:  A Capron; J P Dessaint; M Capron; H Bazin
Journal:  Nature       Date:  1975-02-06       Impact factor: 49.962

4.  Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels.

Authors:  P Rihet; C E Demeure; A Bourgois; A Prata; A J Dessein
Journal:  Eur J Immunol       Date:  1991-11       Impact factor: 5.532

5.  Schistosoma mansoni in the baboon (Papio anubis): parasitological responses of Kenyan baboons to different exposures of a local parasite strain.

Authors:  R F Sturrock; A E Butterworth; V Houba
Journal:  Parasitology       Date:  1976-12       Impact factor: 3.234

6.  Cytotoxicity of human and baboon mononuclear phagocytes against schistosomula in vitro: induction by immune complexes containing IgE and Schistosoma mansoni antigens.

Authors:  M Joseph; A Capron; A E Butterworth; R F Sturrock; V Houba
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

7.  Papio doguera (dog face baboon), a primate reservoir host of Schistosoma mansoni in East Africa.

Authors:  J H MILLER
Journal:  Trans R Soc Trop Med Hyg       Date:  1960-01       Impact factor: 2.184

8.  CD4+ Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage.

Authors:  A T Vella; E J Pearce
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

9.  Human IgE responses to Schistosoma mansoni and resistance to reinfection.

Authors:  D W Dunne; A E Butterworth; A J Fulford; J H Ouma; R F Sturrock
Journal:  Mem Inst Oswaldo Cruz       Date:  1992       Impact factor: 2.743

10.  Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium.

Authors:  P Hagan; U J Blumenthal; D Dunn; A J Simpson; H A Wilkins
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

View more
  13 in total

1.  Morbidity and immune response to natural schistosomiasis in baboons ( Papio anubis).

Authors:  Idle Farah; Andreas Börjesson; Thomas Kariuki; Dorcas Yole; Mbaruk Suleman; Jann Hau; Hans-Erik Carlsson
Journal:  Parasitol Res       Date:  2003-09-18       Impact factor: 2.289

2.  Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine.

Authors:  Thomas M Kariuki; Govert J Van Dam; André M Deelder; Idle O Farah; Dorcas S Yole; R Alan Wilson; Patricia S Coulson
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 3.  Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century.

Authors:  A G Ross; A C Sleigh; Y Li; G M Davis; G M Williams; Z Jiang; Z Feng; D P McManus
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

4.  Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: role of exposure and treatment.

Authors:  P W Mola; I O Farah; T M Kariuki; M Nyindo; R E Blanton; C L King
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Increased allergic immune response to Sarcoptes scabiei antigens in crusted versus ordinary scabies.

Authors:  Shelley F Walton; Susan Pizzutto; Amy Slender; Linda Viberg; Deborah Holt; Belinda J Hales; David J Kemp; Bart J Currie; Jennifer M Rolland; Robyn O'Hehir
Journal:  Clin Vaccine Immunol       Date:  2010-07-14

Review 6.  The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game.

Authors:  Paul Ogongo; Ruth K Nyakundi; Gerald K Chege; Lucy Ochola
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

7.  Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection.

Authors:  Lucia A de Oliveira Fraga; Erika W Lamb; Elizabeth C Moreno; Mitali Chatterjee; Jan Dvořák; Melaine Delcroix; Mohammed Sajid; Conor R Caffrey; Stephen J Davies
Journal:  BMC Immunol       Date:  2010-11-15       Impact factor: 3.615

8.  Mice intranasally immunized with a recombinant 16-kilodalton antigen from roundworm Ascaris parasites are protected against larval migration of Ascaris suum.

Authors:  Naotoshi Tsuji; Kayo Suzuki; Harue Kasuga-Aoki; Takashi Isobe; Takeshi Arakawa; Yasunobu Matsumoto
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Human schistosome infection and allergic sensitisation.

Authors:  Nadine Rujeni; David W Taylor; Francisca Mutapi
Journal:  J Parasitol Res       Date:  2012-08-27

10.  Recent advances in the characterization of genetic factors involved in human susceptibility to infection by schistosomiasis.

Authors:  Amandine Isnard; Christophe Chevillard
Journal:  Curr Genomics       Date:  2008       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.